MALT1 and diffuse large B-cell lymphoma: Recently, small molecule MALT1 protease inhibitors also were described and shown to suppress proliferation of ABC-DLBCL in vitro and in xenotransplanted tumors in vivo[14,15], positioning MALT1 as an attractive anticancer drug target.